Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study - Wikidata - awgldk - TriplyDB

Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study

Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study

http://www.wikidata.org/entity/Q34605699

about

Autoantibodies in chronic hepatitis C: A clinical perspective Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis.

P2860

Q28088556-02656046-E6DE-4876-82AF-DFDF909054D7 Q35633205-92E1EA89-3978-4156-80BE-DD95E8DF7FD7 Q35745075-FF88BDC2-5982-4BAC-905E-4DB1A8EB8B49 Q35914823-F4197E13-0C96-42C5-A003-B0AC93181EA2 Q37266330-F3C2AE50-3B96-4F44-B1DF-31BABE1BBF0C Q50574844-2CCFB7D0-43C7-4415-9C86-3B1FC7E20EBA Q51747614-3E444D21-FEF5-4A38-B30C-B564A779977B

P2860

Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study

http://www.wikidata.org/entity/Q34605699

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Impact of parietal cell autoan ...... virus infection: a pilot study

@ast

Impact of parietal cell autoan ...... virus infection: a pilot study

@en

Impact of parietal cell autoan ...... virus infection: a pilot study

@nl

type

label

Impact of parietal cell autoan ...... virus infection: a pilot study

@ast

Impact of parietal cell autoan ...... virus infection: a pilot study

@en

Impact of parietal cell autoan ...... virus infection: a pilot study

@nl

prefLabel

Impact of parietal cell autoan ...... virus infection: a pilot study

@ast

Impact of parietal cell autoan ...... virus infection: a pilot study

@en

Impact of parietal cell autoan ...... virus infection: a pilot study

@nl

P1433

Q34605699-F1FE9564-56F3-46B6-8B76-9575FA83E26F

P1476

Q34605699-0A52A6AE-CCCC-44CC-B547-65CD61D4A6E1

P2093

Q34605699-13B936EE-0D65-448E-A3DF-A6641207D577

Q34605699-392F8675-C55D-4F35-89F8-3CC48F1AC2C6

Q34605699-54223324-D8C9-4525-AF86-1063C333DF96

Q34605699-8980C8F7-1DBF-4BEE-9187-D0580C814431

Q34605699-C14C0626-FEF3-4EB8-892F-AAC2AF2C821F

Q34605699-E75A8511-AEBA-4114-8529-BAE3EFC3D5F9

Q34605699-E8CCF44C-4A11-43DB-A83D-8575874DEB5B

P2860

Q34605699-02583FE8-0F46-4DFA-B1A6-B5359BBC0221

Q34605699-0B3F862B-7DFA-457D-B178-56DC3D51E483

Q34605699-0FE036C6-37CC-4854-9443-7CD89AD57ABB

Q34605699-130BDBAF-3A16-47AA-BF4B-97853BA4F714

Q34605699-17BCF238-5613-46D7-8557-39AC652CE906

Q34605699-20EFA4C1-329B-4361-B918-307FB2EFB038

Q34605699-24CCA1A2-3F95-4535-BB20-237046D0C4D8

Q34605699-2B0FE37A-BA69-4165-95BD-B27EB2D1B87E

Q34605699-3E9B4E1C-747F-4ABC-9E50-1F3C9E9EB3DA

Q34605699-4552F619-3B44-480F-AD75-151A35F3AF30

P304

Q34605699-70FE661C-E049-4A67-8DF1-393BBB8AC5CE

P31

Q34605699-0EF78F76-7B22-4CCE-90D7-2244FA96D64F

P356

Q34605699-4C5CEC50-754A-4F2A-97FC-76968EFA9EE7

P407

Q34605699-2A8277E5-53FE-402B-974E-47B0A16A006E

P433

Q34605699-02B30D7B-3ECC-41F9-A331-5CCAD1B645F9

P478

Q34605699-5B3AC13B-59AA-4C06-9D0E-B247504409CD

P577

Q34605699-F70C972E-28EC-4DF6-B75E-539E3BF76698

P5875

Q34605699-C382CCD4-F485-4DD3-AE8F-596669CD9C65

P698

Q34605699-648A4C58-9D1C-4692-A6DA-B5F20923B9E1

P921

Q34605699-09C3E6E7-EF14-4A32-AB28-72918E4968A9

P932

Q34605699-E943725B-848B-4147-A3E2-8E1EB2B61903

P356

P1433

World Journal of Gastroenterology

P1476

Impact of parietal cell autoan ...... virus infection: a pilot study

@en

P2093

Angelos Hatzakis

http://www.w3.org/2001/XMLSchema#string

Christos Liaskos

http://www.w3.org/2001/XMLSchema#string

Georgios N Dalekos

http://www.w3.org/2001/XMLSchema#string

Kalliopi Zachou

http://www.w3.org/2001/XMLSchema#string

Nikolaos K Gatselis

http://www.w3.org/2001/XMLSchema#string

Nikolaos Tassopoulos

http://www.w3.org/2001/XMLSchema#string

Sarah P Georgiadou

http://www.w3.org/2001/XMLSchema#string

P2860

The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C

Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort

Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection

Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome.

P304

482-487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I4.482

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8090454

http://www.w3.org/2001/XMLSchema#string

P698

15641130

http://www.w3.org/2001/XMLSchema#string

P921

P932

4250795

http://www.w3.org/2001/XMLSchema#string